Atlas Trials

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Clinical trial NCT05923268 · COMPLETED

Trial details

NCT number
NCT05923268
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Female
Start date
2023-06-04
Primary completion
2024-06-15
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.